Skip to search
Skip to main content
Skip to first result
Harold Varmus - Profiles in Science
Contact
About
Harold Varmus
The Harold Varmus Papers
Home
The Story
Biographical Overview
Retroviruses and the Genetic Origins of Cancer, 1970-1993
AIDS and HIV: Science, Politics, and Controversy, 1981-1993
Basic Science and Congressional Politics: NIH Director, 1993-1999
Memorial Sloan Kettering Cancer Center, 2000-2010, and National Cancer Institute, 2010-2015
Additional Resources
Glossary
Collection Items
search for
Search
Search
Home
Search results
Search
« Previous |
1
-
100
of
360
|
Next »
Sort
by Title (Z-A)
Relevance
Title (A-Z)
Title (Z-A)
Date (oldest to newest)
Date (newest to oldest)
Number of results to display per page
100
per page
per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
List
Gallery
Gallery
Masonry
Masonry
Slideshow
Slideshow
Search Results
×
[Revertant DNA data] (image 3)
1 of 360
[Revertant DNA data] (image 2)
2 of 360
[Revertant DNA data] (image 1)
3 of 360
[Revertant DNA data] (gel 3)
4 of 360
[Revertant DNA data] (gel 2)
5 of 360
[Revertant DNA data] (gel 1)
6 of 360
Viruses as Vehicles of Genetic Change
7 of 360
Viral Replication and Genetics
8 of 360
Varmus's testimony before the Subcommittee on Health and Environment, Committee on Commerce, U.S. House of Representatives
9 of 360
Varmus' remarks at the unveiling of his portrait at NIH
10 of 360
Varmus Portrait Dedicated in Bldg. 1
11 of 360
Varieties of RNA Tumor Virus-Specific DNA in Cells
12 of 360
Using Recombinant DNA Technology to Study the Behavior of Retroviruses
13 of 360
Use of MMTV-Wnt-1 Transgenic Mice for Studying the Genetic Basis of Breast Cancer
14 of 360
Updated Background Information for December 2, 1998 Hearing on Stem Cell Research
15 of 360
Untitled speech from talk at the 5th International Congress of Virology in Strasbourg, France
16 of 360
Untitled slide
17 of 360
UCSF's Nobels: Surprise, Satisfaction and the World Reaction . . .
18 of 360
U.S. Public Health Service Patent and Licensing Principles
19 of 360
Tumor Viruses and Oncogenes
20 of 360
Tumor Viruses
21 of 360
Tree Shaking and Jelly Making: Growing up with Retroviruses
22 of 360
Transcript of Varmus's testimony at Congressional Hearing "Biotechnology and the Ethics of Cloning: How Far Should We Go?"
23 of 360
Three Decades of Wnts: A Personal Perspective on How a Scientific Field Developed
24 of 360
The src Protein Contains Multiple Domains for Specific Attachment to Membranes
25 of 360
The New Era in Cancer Research
26 of 360
The Molecular Genetics of Cellular Oncogenes
27 of 360
The Hunting of the src and "Jumping Genes"
28 of 360
Testimony of Paul Berg, PhD, to the Senate Judiciary Committee Hearing [on Human Cloning]
29 of 360
Testimony of Harold Varmus, MD. . . . House Committee on Energy and Commerce and Senate Committee on Health, Education, Labor, and Pensions: "Managing Biomedical Research to Prevent and Cure Disease in the 21st Century: Matching NIH Policy with Science"
30 of 360
Testimony by Harold Varmus, MD, to the Senate Judiciary Committee Hearing on Human Cloning
31 of 360
Tentative Model for ASV Gene Expression
32 of 360
Telomerase Activation in Mouse Mammary Tumors: Lack of Detectable Telomere Shortening and Evidence for Regulation of Telomerase RNA with Cell Proliferation
33 of 360
Synthesis of ASV DNA - 1976 Version
34 of 360
Status of Viral DNA in Cells Chronically Infected by RNA Tumor Viruses
35 of 360
Statement of Harold Varmus, MD, Director, National Institutes of Health, before the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies
36 of 360
Statement of Harold Varmus, MD, Director, National Institutes of Health, before the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies
37 of 360
Stanford Medical School Graduation Speech
38 of 360
Squirrels Have It
39 of 360
Some General Comments on Cloning and the Use of the P2 Room
40 of 360
Small DNA Viruses
41 of 360
Shattuck Lecture - Biomedical Research Enters the Steady State
42 of 360
Science and the Media
43 of 360
Science Policy in the Next Forty Years
44 of 360
Rous RNA 5/11
45 of 360
Revitalization of the Warren G. Magnuson Clinical Center
46 of 360
Retroviruses
47 of 360
Restriction Endonuclease Cleavage Sites in ASV-DNA
48 of 360
Research proposal to the American Business Cancer Research Foundation
49 of 360
Report of the 3rd International Congress of Virology
50 of 360
Report from Cold Spring Harbor, 1979: Viral Oncogenes (and Other Items)
51 of 360
Recent Evidence for Oncogenesis by Insertion Mutagenesis and Gene Activation
52 of 360
Reasons to Oppose Establishment of a National Center for Complementary and Alternative Medicine
53 of 360
RNA Tumor Viruses
54 of 360
Public Library of Science post
55 of 360
Protocol for the Use of 32p and Other Isotopes
56 of 360
Proposals for Regulation of ASV Genes
57 of 360
Progress report from "Molecular Analysis of Retroviruses and Oncogenes" grant project
58 of 360
Presidential Bioethics Advisors May Well Come Down on the Side of Federal Funding for Research on Stem Cells Derived from Embryos
59 of 360
Possible Model for Viral Gene Expression in Permissive Cells
60 of 360
Possible Model for Viral Gene Expression in Nonpermissive Cells
61 of 360
Portrait of Harold Varmus as NIH Director
62 of 360
Political Maneuvering around Stem Cell Research Issue
63 of 360
PLoS Pronunciation and Usage Key
64 of 360
Ovalbumen, 'Sarc,' and 'Viral' Genes in Chicken Chromosomes
65 of 360
Oncogenesis without Viral Oncogenes by Avian Leukosis and Mouse Mammary Tumor Viruses
66 of 360
On the Nomenclature of Viruses Associated with AIDS
67 of 360
Nucleotide Sequences Related to the Transforming Gene of Avian Sarcoma Virus are Present in DNA of Uninfected Vertebrates
68 of 360
Notes on Genetic Engineering Seminar
69 of 360
Notes from science writers seminar
70 of 360
National Institutes of Health in the Tropics
71 of 360
National Institutes of Health Will Honor Clinton's Commitment to Increase Spinal Cord Injury Research
72 of 360
National Institute of Arthritis and Metabolic Diseases (NIAMD) clinical investigators
73 of 360
Naming the AIDS Virus
74 of 360
NIH Plan for Research in Spinal Cord Injury and Regeneration
75 of 360
NIH Director-Designate Harold Varmus with First Lady Hillary Rodham Clinton
76 of 360
Moral and Ethical Distinctions between Deriving and Using Stem Cells for Research Dog Bioethics Advisory Commission's Deliberations
77 of 360
Minutes of the NIH NCCAM Trans-Agency CAM Coordinating Committee
78 of 360
Minutes of the First Meeting of the PLoS Board of Directors
79 of 360
Memorandum of Understanding and Agreement: Recombinant DNA
80 of 360
Memorandum from Robert J. Huebner, National Institutes of Health to Harold Varmus [regarding Varmus' manuscript on the detection of new and additional virus-specific DNA sequences in chick embryo fibroblasts after infection by RSV]
81 of 360
Memorandum from Harriet Rabb to Harold Varmus [on federal funding for research involving human pluripotent stem cells]
82 of 360
Memorandum from Harold Varmus to the Secretary of Health and Human Services
83 of 360
Memorandum from Harold Varmus to the Grand Challenges in Global Health Scientific Advisory Board
84 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [with the initial set of proposals on the nomenclature of the AIDS virus]
85 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on their final response on the nomenclature of the AIDS virus]
86 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the results of the initial straw poll on the nomenclature of the AIDS virus]
87 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the results of the final poll on the nomenclature of the AIDS virus]
88 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the latest status on the efforts to name the AIDS virus]
89 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the latest poll regarding the nomenclature of the AIDS virus]
90 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the initial call for proposals on the nomenclature of the AIDS virus]
91 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on the final proposal to the medical journals on the nomenclature of the AIDS virus]
92 of 360
Memorandum from Harold Varmus to members of the human retrovirus subcommittee of the Retrovirus Study Group [on a response to a letter from Robert Gallo]
93 of 360
Memorandum from Harold Varmus to Keith Hadley, Campus Biosafety Committee, University of California, San Francisco
94 of 360
Memorandum from Harold Varmus to Gladys Kist and Susan Shultz [on grant application for 1985 Hepatitis B Virus Meeting]
95 of 360
Letter from the Public Library of Science [to signers of the PLoS open letter]
96 of 360
Letter from the Passano Foundation to Harold Varmus and J. Michael Bishop
97 of 360
Letter from Yoji Ikawa, Japanese Foundation for Cancer Research to Harold Varmus
98 of 360
Letter from William S. Robinson, Stanford University Medical Center to Harold Varmus
99 of 360
Letter from William A. Haseltine, Dana-Farber Cancer Institute to Harold Varmus
100 of 360
previous image
next image
Pause Slideshow
Start Slideshow
« Previous
Next »
1
2
3
4